Search

everythinglearnresearchcommunity

for

Search:↓

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Dutasteride may protect the brain in early Parkinson's disease.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

The FDA approved a new Pfizer drug for hair loss in teens.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Tridax procumbens parts have antioxidant properties.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

JAK inhibitors are effective for long-term management of alopecia areata.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

New microneedles deliver drugs through the skin accurately and effectively.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.